Advertisement
JOGC

Évaluation de l’information transmise sur l’avortement médicamenteux dans les cliniques d’avortement du Québec en 2021 – Partie 2

Published:December 22, 2022DOI:https://doi.org/10.1016/j.jogc.2022.11.012

      RÉSUMÉ

      Objectif

      La communication d’informations est un élément phare de la qualité des services. Elle permet de faire un choix éclairé entre l’avortement chirurgical et médicamenteux.

      Méthodes

      Les cliniques d’avortement du Québec ont été contactées par deux clientes secrètes aux profils cliniques (PC) différents, entre le 8 octobre et le 17 novembre 2021. La collecte de données était simultanée. L’unité d’analyse était le PC. Des analyses descriptives et tests statistiques ont été réalisés ainsi qu’une analyse qualitative des commentaires recueillis.

      Résultats

      Sur 17 sujets d’informations jugés nécessaires à un choix éclairé, 35 % ont été obtenus spontanément. Ils portaient sur les tests à effectuer (78 %), les personnes à rencontrer avant l’avortement médicamenteux (77 %), la durée gestationnelle admissible (64 %), les effets indésirables (49 %) (surtout les effets alarmants) et le nombre de consultations requises (42 %). Sur un total de 12 points, le score moyen de qualité des informations était de 7,2 (écart-type [ET] : 2,7). Un score de moins de 7 a été obtenu par 41 % des PC. Les scores de qualité élevés sont associés à une attitude perçue plus aimable de l’interlocutrice et à la transmission spontanée d’un plus grand nombre d’informations. Pour 51 des 78 PC, les médicaments abortifs étaient donnés à la clinique, et pour 13 d’entre eux, la mifépristone devait être prise devant le médecin.

      Conclusion

      Les informations reçues lors d’appels aux cliniques d’avortement du Québec, comme elles sont souvent insuffisantes, permettaient difficilement de faire un choix éclairé entre les méthodes d’avortement. Ce manque d’informations pourrait expliquer la faible proportion d’avortements médicamenteux au Québec.

      Objective

      Communication of information is a key component of quality family planning services. It allows for an informed choice between surgical and medication abortion.

      Methods

      Quebec abortion clinics were contacted by two mystery client clinical profiles (PC) between October 8 and November 17, 2021. Data collection was done simultaneously by a data collector. The unit of analysis was the PC. Descriptive analyses and statistical tests were performed, as well as a qualitative analysis of the collected comments.

      Results

      Of the 17 information topics deemed necessary for an informed choice, 35% were obtained spontaneously. These included what tests to perform (78%), professionals to meet before the procedure (77%), gestational age limit (64%), side effects (49%) (especially alarming ones), and the number of visits required (42%). On a score of 12, the average information quality score was 7.2 (standard deviation [SD] 2.7). A score of less than 7/12 was obtained by 41% of PCs. A high information quality score was associated with a perceived friendlier attitude of the person responding to the call and the unprompted transmission of more information. For 51/78 PCs, abortifacient medications were served at the clinic, and for 13 of them, the first medication had to be taken in front of the physician.

      Conclusion

      The information received when calling Quebec abortion clinics for an appointment for abortion was often insufficient and made it difficult to make an informed choice between the two methods of abortion. This may explain the low proportion of medication abortion in Quebec.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Obstetrics and Gynaecology Canada
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      Références

        • Bruce J.
        Fundamental elements of the quality of care: a simple framework.
        Stud Fam Plann. avr. 1990; 21: 61-91
        • Jain A.K.
        • Hardee K.
        Revising the FP Quality of Care Framework in the Context of Rights-based Family Planning: Revising the FP Quality of Care Framework in the Context of Rights-based Family Planning. Studies in Family Planning.
        juin. 2018; 49: 171-179
        • Holt K.
        • Dehlendorf C.
        • Langer A.
        Defining quality in contraceptive counseling to improve measurement of individuals’ experiences and enable service delivery improvement.
        Contraception. sept. 2017; 96: 133-137
        • Gavin L.E.
        • Ahrens K.A.
        • Dehlendorf C.
        • Frederiksen B.N.
        • Decker E.
        • Moskosky S.
        Future directions in performance measures for contraceptive care: a proposed framework.
        Contraception. sept. 2017; 96: 138-144
        • Rathert C.
        • Wyrwich M.D.
        • Boren S.A.
        Patient-Centered Care and Outcomes: A Systematic Review of the Literature.
        Med Care Res Rev. août. 2013; 70: 351-379
        • Dehlendorf C.
        • Grumbach K.
        • Schmittdiel J.A.
        • Steinauer J.
        Shared decision making in contraceptive counseling.
        Contraception. mai. 2017; 95: 452-455
        • Coleman-Minahan K.
        • Potter J.E.
        Quality of postpartum contraceptive counseling and changes in contraceptive method preferences.
        Contraception. déc. 2019; 100: 492-497
        • Dehlendorf C.
        • Krajewski C.
        • Borrero S.
        Contraceptive Counseling: Best Practices to Ensure Quality Communication and Enable Effective Contraceptive Use. Clinical Obstetrics & Gynecology.
        déc. 2014; 57: 659-673
        • Lara D.
        • Abuabara K.
        • Grossman D.
        • Díaz-Olavarrieta C.
        Pharmacy provision of medical abortifacients in a Latin American city.
        Contraception. nov. 2006; 74: 394-399
        • Lara D.
        • García S.G.
        • Wilson K.S.
        • Paz F.
        How Often and Under Which Circumstances Do Mexican Pharmacy Vendors Recommend Misoprostol To Induce an Abortion? International Perspectives on Sexual and Reproductive Health.
        juin. 2011; 37075-83
      1. Diamond-Smith N, Percher J, Saxena M, Dwivedi P, Srivastava A. Knowledge, provision of information and barriers to high quality medication abortion provision by pharmacists in Uttar Pradesh, India. BMC Health Services Research [Internet]. déc 2019 [cité le 20 mai 2021];19(1). Disponible sur : https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-019-4318-4

        • Moore A.M.
        • Blades N.
        • Ortiz J.
        • Whitehead H.
        • Villarreal C.
        What does informal access to misoprostol in Colombia look like? A mystery client methodology in Bogotá and the Coffee Axis.
        BMJ Sexual & Reproductive Health. oct 2020; 46: 294-300
        • Billings D.L.
        • Walker D.
        • Mainero del Paso G.
        • Clark K.A.
        • Dayananda I.
        Pharmacy worker practices related to use of misoprostol for abortion in one Mexican state.
        Contraception. juin. 2009; 79: 445-451
        • Moore A.M.
        • Philbin J.
        • Ariawan I.
        • Budiharsana M.
        • Murro R.
        • Aryanty R.I.
        • et al.
        Online Abortion Drug Sales in Indonesia: A Quality of Care Assessment. Studies in Family Planning.
        déc. 2020; 51: 295-308
        • Bryant A.G.
        • Levi E.E.
        Abortion misinformation from crisis pregnancy centers in North Carolina. Contraception.
        déc. 2012; 86: 752-756
        • LaRoche K.J.
        • Foster A.M.
        Toll free but not judgment free: evaluating postabortion support services in Ontario.
        Contraception. nov. 2015; 92: 469-474
        • Anand P.
        • McAllister A.
        • Hunter T.
        • Schreiber C.A.
        • Koelper N.
        • Sonalkar S.
        A simulated patient study to assess referrals to abortion care by student health centers in Pennsylvania.
        Contraception. juill. 2020; 102: 23-29
        • Guilbert E.
        • Wagner M.S.
        • Munro S.
        • Wilcox E.S.
        • Dunn S.
        • Soon J.A.
        • et al.
        Slow implementation of mifepristone medical termination of pregnancy in Quebec, Canada: a qualitative investigation.
        The European Journal of Contraception & Reproductive Health Care. 3 mai 2020; 25: 190-198
      2. Munro S, Guilbert E, Wagner M-S, Wilcox E, Devane C, Dunn S, Brooks M, Soon J, Mills M, Leduc-Robert G, Whahl K, Zannier E, Norman WV. Factors influencing implementation of mifepristone medical abortion among Canadian physicians: a national qualitative study. CMAJ: Canadian Medical Association journal = journal de l’Association médicale canadienne. Submitted. 2019;

        • Ennis M.
        • Wahl K.
        • Jeong D.
        • Knight K.
        • Renner R.
        • Munro S.
        • et al.
        The perspective of Canadian health care professionals on abortion service during the COVID-19 pandemic.
        Family Practice. 27 août 2021; 38: i30-6
      3. Guilbert E, Bois G. Évaluation de l’accès à l’avortement médicamenteux dans les cliniques d’avortement du Québec en 2021. Journal of Obstetrics and Gynaecology Canada. 2022;Submitted for publication.

        • Ogrinc G.
        • Davies L.
        • Goodman D.
        • Batalden P.
        • Davidoff F.
        • Stevens D.
        SQUIRE 2.0 ( Standards for QUality Improvement Reporting Excellence) : revised publication guidelines from a detailed consensus process: Table 1.
        BMJ Qual Saf. déc. 2016; 25: 986-992
      4. Bottin des ressources en avortement au Québec 2020 [Internet]. Fédération québécoise pour le planning des naissances; 2020 [cité le 20 oct 2020]. Disponible sur : www.fqpn.qc.ca

      5. Conditions menant à conclure qu’une approbation éthique n’est pas requise [Internet]. Université Laval; 2010 [cité le 26 janv 2022]. Disponible sur : https://www.cerul.ulaval.ca/wp-content/uploads/2021/05/Derogation-projet-professeurs.pdf

      6. Lignes directrices proposées pour les demandes d’avis basées sur l’article 2.5 EPCT2 [Internet]. Direction de la qualité, de l’évaluation, de l’éthique et des affaires institutionnelles. CHU de Québec - Université Laval; 2020 [cité le 26 janv 2022]. Disponible sur : https://ethics.gc.ca/fra/tcps2-eptc2_2018_chapter2-chapitre2.html#5

      7. Chi-square Test Calculator [Internet]. Social Science Statistics; 2022 [cité le 10 févr 2022]. Disponible sur : https://www.socscistatistics.com/tests/chisquare2/default2.aspx

      8. Easy Fisher Exact Test Calculator [Internet]. Social Science Statistics; 2022 [cité le 10 févr 2022]. Disponible sur : https://www.socscistatistics.com/tests/fisher/default2.aspx

        • Costescu D.
        • Guilbert E.
        • Bernardin J.
        • Black A.
        • Dunn S.
        • Fitzsimmons B.
        • et al.
        Medical Abortion.
        J Obstet Gynaecol Can. avr. 2016; 38: 366-389
        • Dodge L.E.
        • Haider S.
        • Hacker M.R.
        Knowledge of State-Level Abortion Laws and Policies among Front-Line Staff at Facilities Providing Abortion Services.
        Women’s Health Issues. sept. 2012; 22e415-20
      9. World Health Organization. Abortion care guideline [Internet]. World Health Organization; 2022 [cité le 5 avr 2022]. Disponible sur : https://apps.who.int/iris/handle/10665/349316